트립타민 API 시장 - 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2031년) - 등급별, 원료별, 용도별, 지역별

Tryptamines API Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

US $ 4,995 ￦ 6,828,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 11,613,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 14,491,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 트립타민 API(원료의약품) 시장 규모는 크게 성장하여 2024년 6억 3,000만 달러의 매출을 기록할 것으로 예상됩니다. 이 시장은 빠르게 성장하여 2031년 말에는 1조 6,500억 달러 규모에 달할 것으로 예상됩니다.

트립타민 API 시장은 편두통 질환의 유병률 증가, 트립타민의 잠재적 항암 효과, 신경 및 정신 질환의 치료제로서의 트립타민 탐색 등 여러 가지 요인으로 인해 성장하고 있습니다. 특히 북미에서는 편두통 및 기타 신경 질환의 치료에 트립타민 API가 점점 더 많이 사용되고 있기 때문에 특수 의약품에 대한 수요가 트립타민 API 시장의 성장에 기여하고 있습니다.

편두통은 가장 흔한 신경 질환 중 하나로 연간 10억 명 이상이 앓고 있습니다. 편두통의 발병은 복잡하고 다양한 사회적, 생물학적 위험 요인이 존재하기 때문에 효과적인 치료법에 대한 수요가 증가하면서 트립타민 API 시장을 주도하고 있습니다. 트립타민 환각제를 포함한 정신작용성 화학물질의 신경학적 효과에 대한 연구는 그 치료적 잠재력을 인정받으면서 증가하고 있습니다. 다양한 신경 및 정신 질환 치료에 대한 트립타민의 탐색은 시장 성장을 촉진할 것으로 예상됩니다.

이 보고서는 세계 트립타민 API 시장에 대해 조사했으며, 시장 개요와 함께 등급별/원료별/용도별/지역별 동향, 시장 진출기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter의 Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나와 러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 생산량과 무역 통계, 2018년-2023년

제4장 가격 분석, 2018년-2023년

제5장 세계의 트립타민 API 시장 전망, 2018년-2031년

• 세계의 트립타민 API 시장 전망, 등급별, 금액(10억 달러), 수량(kg), 2018년-2031년
• 세계의 트립타민 API 시장 전망, 원료별, 금액(10억 달러), 수량(kg), 2018년-2031년
• 세계의 트립타민 API 시장 전망, 용도별, 금액(10억 달러), 수량(kg), 2018년-2031년
• 세계의 트립타민 API 시장 전망, 지역별, 금액(달러), 수량(kg), 2018년-2031년

제6장 북미의 트립타민 API 시장 전망, 2018년-2031년

제7장 유럽의 트립타민 API 시장 전망, 2018년-2031년

제8장 아시아태평양의 트립타민 API 시장 전망, 2018년-2031년

제9장 라틴아메리카의 트립타민 API 시장 전망, 2018년-2031년

제10장 중동 및 아프리카의 트립타민 API 시장 전망, 2018년-2031년

제11장 경쟁 구도

• 최종사용자별과 원료별 히트맵
• 제조업체와 원료별 히트맵
• 기업의 시장 점유율 분석, 2023년
• 경쟁력 대시보드
• 기업 개요
  • Merck
  • Avra Synthesis Private Limited
  • Spectrum Chemical
  • Cayman Chemical Company(Matreya)
  • Tokyo Chemical Industry Co. Ltd.
  • Santa Cruz Biotechnology, Inc.
  • LGC Standards
  • Avra Synthesis Private Limited
  • SimSon Pharma Limited
  • Glentham Life

제12장 부록

LSH

영문 목차

영문목차

The Global Tryptamines API (Active Pharmaceutical Ingredient) Market has witnessed substantial growth, recording revenue of US$ 630 million in 2024. The market is projected to continue its rapid expansion, aiming to reach a valuation of US$ 1650 billion by the end of 2031, according to a recent report released by Fairfield Market Research.

Key Market Highlights:

• Tryptamines and Their Significance: Tryptamines are monoamine alkaloids found in mammals, fungi, and plants, with structural similarities to the amino acid tryptophan. They serve as the foundation for various biologically active substances, including psychedelic drugs and neurotransmitters.

• Market Growth Drivers: The market for Tryptamines APIs is experiencing growth due to several factors, including the rising prevalence of migraine disorders, the potential anti-cancer effects of tryptamine, and the exploration of tryptamines for therapeutic use in neurological and psychiatric conditions.

• Demand for Specialized Pharmaceuticals: The need for specialized pharmaceuticals, particularly in North America, has contributed to the growth of the Tryptamines API market, as these APIs are increasingly utilized in the treatment of migraine and other neurological conditions.

Factors Fueling Market Growth:

• Prevalence of Migraine Disorders: Migraine is one of the most common neurological disorders, affecting over one billion people annually. The complexity of migraine development, along with various social and biological risk factors, has led to an increased demand for effective treatments, driving the market for Tryptamines APIs.

• Psychoactive Chemicals and Therapeutic Potential: Research into the neurological effects of psychoactive chemicals, including tryptamine psychedelics, has grown due to their perceived therapeutic potential. The exploration of tryptamines for treating various neurological and psychiatric conditions is expected to fuel market growth.

Challenges Affecting Market Growth:

• High Capital Investment: The manufacturing of Tryptamines APIs involves significant capital investment due to various factors, including infrastructure, equipment, and quality standards. These high capital requirements may hinder market growth.

Key Market Dynamics:

• United States Market Surge: North America, particularly the United States, is expected to dominate the Tryptamines API market due to the region's increasing demand for specialized pharmaceuticals and the high prevalence of migraine disorders.

• Germany's Lucrative Market: Germany offers numerous advantages for Tryptamines API manufacturers, including investments in R&D projects and the presence of significant regional market participants.

• China's Growing Market: China is becoming a prominent market for Tryptamines APIs, with Chinese API producers obtaining globally recognized Good Manufacturing Practice (GMP) accreditation.

Highly Sought-after API Grade: GMP-grade Tryptamines APIs, produced in compliance with established quality standards for clinical use, are in high demand.

Preferred Source of Tryptamines APIs: Synthetic chemical APIs, known as small molecules, are widely used in the pharmaceutical industry. They include medications like sumatriptan, ondansetron, and alosetron.

Competitive Landscape:

Major market players are focusing on expansion strategies to tap into potential markets, emphasizing the mass production of GMP-compliant products with market potential in underdeveloped regions.

Key Companies in the Market:

• Merck
• Spectrum Chemical
• LGC Standards
• Cayman Chemical Company (Matreya)
• Psygen
• Biosynth
• Clearsynth Labs
• Glentham Life
• Pharmaffiliates Analytics and Synthetics P. Ltd.
• Santa Cruz Biotechnology, Inc.
• SimSon Pharma Limited
• Otto Chemie Pvt. Ltd
• Tokyo Chemical Industry Co. Ltd.
• Avra Synthesis Private Limited

Market Segmentation

Grade:

• GMP Grade
• Non-GMP Grade

Source:

• Natural
• Synthetic
• Bio-Synthetic

Application:

• Clinical Use
• Research Use

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Tryptamines API Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume, 2023
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

• 3.1. Global Tryptamines API Market Production Output, by Region, Value (US$ Bn) and Volume (in Kgs), 2018 - 2023
  • 3.1.1. North America
  • 3.1.2. Europe
  • 3.1.3. Asia Pacific
  • 3.1.4. Latin America
  • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

• 4.1. Global Average Price Analysis, by Grade/ Material, US$ Per Unit, 2018 - 2023
• 4.2. Prominent Factor Affecting Peripheral Stent Implants Prices
• 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Tryptamines API Market Outlook, 2018 - 2031

• 5.1. Global Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. GMP Grade
    • 5.1.1.2. Non-GMP Grade
• 5.2. Global Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Natural
    • 5.2.1.2. Synthetic
    • 5.2.1.3. Bio-Synthetic
• 5.3. Global Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Clinical Use
    • 5.3.1.2. Research Use
• 5.4. Global Tryptamines API Market Outlook, by Region, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 5.4.1. Key Highlights
    • 5.4.1.1. North America
    • 5.4.1.2. Europe
    • 5.4.1.3. Asia Pacific
    • 5.4.1.4. Latin America
    • 5.4.1.5. Middle East & Africa

6. North America Tryptamines API Market Outlook, 2018 - 2031

• 6.1. North America Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. GMP Grade
    • 6.1.1.2. Non-GMP Grade
• 6.2. North America Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Natural
    • 6.2.1.2. Synthetic
    • 6.2.1.3. Bio-Synthetic
• 6.3. North America Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. Clinical Use
    • 6.3.1.2. Research Use
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis
• 6.4. North America Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 6.4.1. Key Highlights
    • 6.4.1.1. U.S. Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.4.1.2. U.S. Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.4.1.3. U.S. Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.4.1.4. Canada Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.4.1.5. Canada Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.4.1.6. Canada Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Tryptamines API Market Outlook, 2018 - 2031

• 7.1. Europe Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 7.1.1. Key Highlights
    • 7.1.1.1. GMP Grade
    • 7.1.1.2. Non-GMP Grade
• 7.2. Europe Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 7.2.1. Key Highlights
    • 7.2.1.1. Natural
    • 7.2.1.2. Synthetic
    • 7.2.1.3. Bio-Synthetic
• 7.3. Europe Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 7.3.1. Key Highlights
    • 7.3.1.1. Clinical Use
    • 7.3.1.2. Research Use
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis
• 7.4. Europe Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 7.4.1. Key Highlights
    • 7.4.1.1. Germany Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.2. Germany Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.3. Germany Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.4. U.K. Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.5. U.K. Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.6. U.K. Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.7. France Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.8. France Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.9. France Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.10. Italy Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.11. Italy Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.12. Italy Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.13. Turkey Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.14. Turkey Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.15. Turkey Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.16. Russia Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.17. Russia Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.18. Russia Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.19. Rest of Europe Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.20. Rest of Europe Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1.21. Rest of Europe Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Tryptamines API Market Outlook, 2018 - 2031

• 8.1. Asia Pacific Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 8.1.1. Key Highlights
    • 8.1.1.1. GMP Grade
    • 8.1.1.2. Non-GMP Grade
• 8.2. Asia Pacific Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 8.2.1. Key Highlights
    • 8.2.1.1. Natural
    • 8.2.1.2. Synthetic
    • 8.2.1.3. Bio-Synthetic
• 8.3. Asia Pacific Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 8.3.1. Key Highlights
    • 8.3.1.1. Clinical Use
    • 8.3.1.2. Research Use
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis
• 8.4. Asia Pacific Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 8.4.1. Key Highlights
    • 8.4.1.1. China Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.2. China Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.3. China Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.4. Japan Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.5. Japan Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.6. Japan Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.7. South Korea Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.8. South Korea Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.9. South Korea Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.10. India Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.11. India Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.12. India Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.13. Southeast Asia Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.14. Southeast Asia Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.15. Southeast Asia Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.16. Rest of Asia Pacific Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.17. Rest of Asia Pacific Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1.18. Rest of Asia Pacific Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Tryptamines API Market Outlook, 2018 - 2031

• 9.1. Latin America Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 9.1.1. Key Highlights
    • 9.1.1.1. GMP Grade
    • 9.1.1.2. Non-GMP Grade
• 9.2. Latin America Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 9.2.1.1. Natural
  • 9.2.1.2. Synthetic
  • 9.2.1.3. Bio-Synthetic
• 9.3. Latin America Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 9.3.1. Key Highlights
    • 9.3.1.1. Clinical Use
    • 9.3.1.2. Research Use
  • 9.3.2. BPS Analysis/Market Attractiveness Analysis
• 9.4. Latin America Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 9.4.1. Key Highlights
    • 9.4.1.1. Brazil Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1.2. Brazil Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1.3. Brazil Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1.4. Mexico Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1.5. Mexico Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1.6. Mexico Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1.7. Argentina Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1.8. Argentina Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1.9. Argentina Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1.10. Rest of Latin America Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1.11. Rest of Latin America Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1.12. Rest of Latin America Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Tryptamines API Market Outlook, 2018 - 2031

• 10.1. Middle East & Africa Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 10.1.1. Key Highlights
    • 10.1.1.1. GMP Grade
    • 10.1.1.2. Non-GMP Grade
• 10.2. Middle East & Africa Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 10.2.1. Key Highlights
    • 10.2.1.1. Natural
    • 10.2.1.2. Synthetic
    • 10.2.1.3. Bio-Synthetic
• 10.3. Middle East & Africa Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 10.3.1. Key Highlights
    • 10.3.1.1. Clinical Use
    • 10.3.1.2. Research Use
  • 10.3.2. BPS Analysis/Market Attractiveness Analysis
• 10.4. Middle East & Africa Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 10.4.1. Key Highlights
    • 10.4.1.1. GCC Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.2. GCC Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.3. GCC Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.4. South Africa Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.5. South Africa Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.6. South Africa Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.7. Egypt Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.8. Egypt Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.9. Egypt Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.10. Nigeria Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.11. Nigeria Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.12. Nigeria Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.13. Rest of Middle East & Africa Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.14. Rest of Middle East & Africa Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1.15. Rest of Middle East & Africa Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
  • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

• 11.1. By End User vs by Source Heat map
• 11.2. Manufacturer vs by Source Heatmap
• 11.3. Company Market Share Analysis, 2023
• 11.4. Competitive Dashboard
• 11.5. Company Profiles
  • 11.5.1. Merck
    • 11.5.1.1. Company Overview
    • 11.5.1.2. Product Portfolio
    • 11.5.1.3. Financial Overview
    • 11.5.1.4. Business Strategies and Development
  • 11.5.2. Avra Synthesis Private Limited
    • 11.5.2.1. Company Overview
    • 11.5.2.2. Product Portfolio
    • 11.5.2.3. Financial Overview
    • 11.5.2.4. Business Strategies and Development
  • 11.5.3. Spectrum Chemical
    • 11.5.3.1. Company Overview
    • 11.5.3.2. Product Portfolio
    • 11.5.3.3. Financial Overview
    • 11.5.3.4. Business Strategies and Development
  • 11.5.4. Cayman Chemical Company (Matreya)
    • 11.5.4.1. Company Overview
    • 11.5.4.2. Product Portfolio
    • 11.5.4.3. Financial Overview
    • 11.5.4.4. Business Strategies and Development
  • 11.5.5. Tokyo Chemical Industry Co. Ltd.
    • 11.5.5.1. Company Overview
    • 11.5.5.2. Product Portfolio
    • 11.5.5.3. Financial Overview
    • 11.5.5.4. Business Strategies and Development
  • 11.5.6. Santa Cruz Biotechnology, Inc.
    • 11.5.6.1. Company Overview
    • 11.5.6.2. Product Portfolio
    • 11.5.6.3. Financial Overview
    • 11.5.6.4. Business Strategies and Development
  • 11.5.7. LGC Standards
    • 11.5.7.1. Company Overview
    • 11.5.7.2. Product Portfolio
    • 11.5.7.3. Financial Overview
    • 11.5.7.4. Business Strategies and Development
  • 11.5.8. Avra Synthesis Private Limited
    • 11.5.8.1. Company Overview
    • 11.5.8.2. Product Portfolio
    • 11.5.8.3. Financial Overview
    • 11.5.8.4. Business Strategies and Development
  • 11.5.9. SimSon Pharma Limited
    • 11.5.9.1. Company Overview
    • 11.5.9.2. Product Portfolio
    • 11.5.9.3. Financial Overview
    • 11.5.9.4. Business Strategies and Development
  • 11.5.10. Glentham Life
    • 11.5.10.1. Company Overview
    • 11.5.10.2. Product Portfolio
    • 11.5.10.3. Financial Overview
    • 11.5.10.4. Business Strategies and Development

12. Appendix

• 12.1. Research Methodology
• 12.2. Report Assumptions
• 12.3. Acronyms and Abbreviations

관련자료